1. Home
  2. SPIR vs CTNM Comparison

SPIR vs CTNM Comparison

Compare SPIR & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spire Global Inc.

SPIR

Spire Global Inc.

HOLD

Current Price

$10.41

Market Cap

347.1M

ML Signal

HOLD

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

HOLD

Current Price

$9.15

Market Cap

416.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPIR
CTNM
Founded
2012
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
347.1M
416.1M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
SPIR
CTNM
Price
$10.41
$9.15
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$12.10
$18.60
AVG Volume (30 Days)
906.7K
290.2K
Earning Date
12-17-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.81
N/A
Revenue
$77,387,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.87
N/A
P/E Ratio
$11.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.60
$3.35
52 Week High
$21.43
$14.90

Technical Indicators

Market Signals
Indicator
SPIR
CTNM
Relative Strength Index (RSI) 64.58 30.36
Support Level $7.36 $11.66
Resistance Level $9.72 $11.73
Average True Range (ATR) 0.67 0.80
MACD 0.27 -0.35
Stochastic Oscillator 93.97 12.86

Price Performance

Historical Comparison
SPIR
CTNM

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: